Where does Xenotherapeutics Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Xenotherapeutics Corporation ranks #18,303 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Xenotherapeutics Corporation hold?

Xenotherapeutics Corporation holds 16 US utility patents granted between 2020 and 2025, spanning 9 technology areas.

What is Xenotherapeutics Corporation's Innovation Score?

Xenotherapeutics Corporation has an Innovation Score of 34.0 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Xenotherapeutics Corporation's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Xenotherapeutics Corporation.

What does claim depth mean for Xenotherapeutics Corporation's patents?

Xenotherapeutics Corporation's patents average 19.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Xenotherapeutics Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Xenotherapeutics Corporation

Q: What technology areas does Xenotherapeutics Corporation focus on?

Xenotherapeutics Corporation's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 16 patents, ranking #665 of 4,144 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 9 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Xenotherapeutics ranks #18,303 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 9 technology areas.

#18,303
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (34.0/100): 19.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R18303 · US Corporation #18,303 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 16 grants
MID-PACK #18,303/49,997
PHOTO-FINISH Worthen Industries
CPC-NARROW C12N · 9 areas
INNOV-THIN 34.0/100
CLAIMS-RICH 19.8 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Worthen Industries (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Xenotherapeutics’s 34.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (29%) Velocity 1.7 pts (5%) Breadth 10.6 pts (31%) Claim depth 11.9 pts (35%)

Qualcomm Incorporated · highest

85
Xenotherapeutics · this assignee

34
3D Lighting… · lowest

7

What this shows Xenotherapeutics's Innovation Score is 34.0/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Xenotherapeutics?

Each dot is one of Xenotherapeutics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Xenotherapeutics’s own 19.8 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Xenotherapeutics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Xenotherapeutics's grants concentrate

Xenotherapeutics Corporation is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (10 grants) versus a trough of 1 in 2023. By volume, Xenotherapeutics sits between Worthen Industries and XiDrone Systems, Inc..

Xenotherapeutics's three-year grant acceleration

Xenotherapeutics Corporation shows 3 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Worthen Industries

16
X-energy

16
X4 Pharmaceuticals

16
Xebec Technology

16
Xi'an Creation Ke…

16
Xtreme Orthopedics

16
XY

16
Xidrone Systems

16
Xenotherapeutics ◀

16

What this shows Xenotherapeutics holds 16 patents at rank #18,299, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xenotherapeutics

By rank, the assignees closest to #18,299 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Xenotherapeutics's primary technology class.

Xenotherapeutics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Xenotherapeutics Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	12.5%
2021	10	62.5%
2022	2	12.5%
2023	1	6.3%
2025partial year	1	6.3%

Which technologies does Xenotherapeutics Corporation patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 16

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 15

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 7

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Xenotherapeutics Corporation's patent record in context - here's where to go next.

Xenotherapeutics Corporation's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #18,303 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Xenotherapeutics Corporation against Worthen Industries, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.